China Resources Pharmaceutical Plans Indirect Acquisition of About 23.50% Stake in Lier Chemical

南方财经网··Read original
3▲3 ▼0Impact / 5
Summary · why it matters

China Resources Pharmaceutical has issued an inside information announcement stating that its indirect non-wholly-owned subsidiary, China Resources Double-Crane Pharmaceutical, intends to acquire approximately 23.50% of the shares in Lier Chemical. The transaction involves 188.1027 million shares of Lier Chemical, initiated by Sichuan Jiuyuan Investment Holding Group and Sichuan Huacai Technology through a public solicitation transfer. As of the announcement date, China Resources Double-Crane does not hold any shares in Lier Chemical. The potential acquisition is still subject to the signing of a formal transaction agreement and the satisfaction of relevant conditions, and there are uncertainties.

Impact on assets 3

Biotech & Genomic Medicine▲
Others▲
Lier Chemical Co Ltd
002258
▲ PositiveCapitalrelevance

Lier Chemical is the target of a 23.50% stake acquisition by China Resources Double-Crane, likely boosting its valuation.

Off-coverage companies 2

Sichuan Jiuyuan Investment Holding Group Co Ltdi
Private± Mixedrelevance

四川化材科技有限公司i
Private± Mixedrelevance